In many public health care systems treatment is rationed by waiting time. We examine the optimal allocation of a …xed supply of a treatment between di¤erent groups of patients. Even in the absence of any distributional aims welfare is increased by third degree waiting time discrimination. Because waiting time imposes dead weight losses on patients, lower waiting times should be o¤ered to groups with higher marginal waiting time costs and with less elastic demand for the treatment.
Introduction
Waiting times are used as a rationing mechanism for elective surgery in many countries with tax or public health insurance …nance. Examples include Australia, Canada, Denmark, Finland, the Netherlands, Spain and the United Kingdom. Average waiting times for common procedures, such as hip and knee replacement, cataract surgery or varicose veins, of six months are not uncommon (Siciliani and Hurst, 2005) .
The question we consider is whether di¤erent types of potential patients (young vs old, men vs women, northerners vs southerners) waiting for the same treatment should face di¤erent waiting times. We do not investigate whether types with di¤erent demands (at a given waiting time) for the treatment should have di¤erent amounts allocated to them. Rather we ask whether di¤erent types should face di¤erent waits, so that the marginal patients of di¤erent types have di¤erent bene…ts from the treatment. We show that in general it is welfare increasing to set di¤erent waiting times for di¤erent groups of patients waiting for the same treatment.
When treatment is rationed by waiting time there are no public sector revenue consequences of changing the allocation of a given amount of treatment between two groups of potential patients. Choosing the allocation of a given supply of treatment between the two groups is equivalent to determining their waiting times.
Individuals di¤er in their health gains from treatment and the marginal patient in a group places a value on the health gain which is equal to their waiting time cost. Suppose that the two groups have the same preferences but have di¤erent distributions of health gains from treatment. With equal waiting times for the two groups, the health gains of the marginal treated patient in each group are equal. Switching a unit of treatment from group A to group B will not alter production costs. Nor will it change the total health gain from treatment since the marginal patient in each group has the same health gain. But the switch will lead to a higher waiting time in group A and a lower waiting time in group B.
Waiting time is a deadweight loss: it imposes costs on patients which are not o¤set by gains to anyone else. If group A has a more waiting time elastic demand than group B then the total waiting time of group A patients will fall by more than the increase in total waiting time of group B patients and total waiting time over all patients will fall. Hence waiting time discrimination in favour of the group with the less elastic is welfare increasing. If the two groups have di¤erent preferences as well as a di¤erent distribution of health gains then the direction of discrimination will also depend on the marginal 1 cost of waiting per treated patient in the two groups. But the conclusion is the same: in general it is welfare increasing to o¤er di¤erent waiting times to di¤erent groups of patients. Notice that the discrimination does not arise from any wish to favour one group over another on distributional grounds nor does it arise from a need to raise revenue as might be the case if care was rationed by user charges.
The results provide support for the prioritisation schemes such as those in Canada, New Zealand, Spain and Sweden (Siciliani and Hurst, 2005) which set di¤erent waiting times for di¤erent types of patient waiting for the same treatment. They also have implications for the allocation of resources across regions and debates over post code rationing. If patients in di¤erent regions have di¤erent preferences or distributions of bene…ts from treatment then optimal geographical resource allocation will yield di¤erent waiting times for the same treatment in di¤erent regions.
In a previous paper (Gravelle and Siciliani, 2007a) we examined linear prioritisation rules where the waiting time for patients varied linearly according to some characteristic such as age. We showed that linear prioritisation was welfare increasing unless the age and health bene…t had a particular type of joint distribution. The categorical prioritisation scheme considered in this paper is more general in that it does not require that waiting times are linear, or even monotonic, with respect to observable patient characteristics. With categorical prioritisation waits could be high for the old and young and low for the middle aged. Since categorical prioritisation is more general, the conditions under which it is welfare increasing are weaker than with linear prioritisation. All that is necessary is that is possible to de…ne categories of patients with either di¤erent preferences or di¤erent distributions of health gain so that they have either di¤erent marginal costs of waiting or di¤erent demand elasticities.
There are two related literatures. The …rst examines the optimal allocation of a health care budget across di¤erent treatments (Garber, 2000, Gravelle and Siciliani, 2007b; Hoel, 2007; Smith, 2005) . In this paper we examine allocation within a treatment to di¤erent groups of patients. The allocation rule used within a treatment will a¤ect the marginal value of resources devoted to a treatment and hence the optimal allocation of a budget across treatments. The second literature examines the optimal mix of money and time prices to ration treatment (Gravelle and Siciliani, 2007c; Hoel and Saether 2003; Marchand and Schroyan, 2004) . Our conclusion that waiting time discrimination within treatments increases welfare from rationing by waiting has implications for the optimal mix of money and waiting time prices.
Section 2 describes patient preferences and demand and sets out the welfare function. Section 3 shows that the optimal allocation requires third degree waiting time discrimination. Section 4 shows that the results hold in more general speci…cations when demand for public sector care depends on income and patients also have the option of buying care in the private sector where there is no wait. Section 5 concludes.
2 Rationing by waiting time
Preferences and demand
All health care is produced in a public health care system. We consider the implications of a private sector alternative in Section 4. Demand for treatment in the public sector is rationed by waiting. To reduce notational clutter we initially assume there are no user charges and relax this assumption in Section 4. h 2 [h min ; h max ] is the health gain or bene…t from treatment. There are two types or groups of individual j = A; B with di¤erent density and distribution functions f j (h) and F j (h). The total population is normalised to 1. The proportion of the population in group j is j and P j j = 1. We assume that all individuals of a given type have the same preferences but di¤erent types may have di¤erent preferences. Allowing for di¤erences in preferences within groups merely complicates the analysis and does not alter the results. If ill and not treated an individual of type j has utility v N T j . Treated patients in group j have a wait of w j before receiving one unit of treatment which produces health gain h. Utility if treated v T j (h; w j ) is increasing in health gain and decreasing in the wait:
We do not need to consider utility or welfare for well individuals since allocating a …xed amount of a treatment between groups has no e¤ect on the utility or welfare of individuals who are not ill. The key assumption is that increases in waiting time reduce the utility from treatment compared with the no treatment alternative.
The most salient form of rationing by waiting time is rationing by waiting list for elective care. Individuals bear a cost in getting on the waiting list for treatment. In systems with gatekeeping general practitioners, patients …rst have to consult their general practitioner to get a referral and then incur further costs in attending hospital outpatient department to be seen by a specialist who will then place them on a waiting list. The longer the time patients have to wait on the list, the less the discounted value of the treatment and the less likely are they to be willing to incur the initial costs of joining the list (Lindsay and Feigenbaum, 1984; Martin and Smith, 1999; Farnworth, 2003) . 2 In some systems there is rationing by waiting in line (queues). Waiting for treatment has an opportunity cost of forgone work or leisure time, as well as possible e¤ects on the health gain. Rationing by waiting line can be used for minor ailments in hospital accident and emergency rooms and for general practitioner consultations. Our speci…cation encompasses both rationing by waiting list and by waiting line and does not restrict the way in which longer waits reduce the utility of treatment relative to no treatment (Hoel and Saether, 2003) .
An individual of type j demands treatment if and only if
whereĥ j (w j ) is the threshold health gain such that all those with a smaller gain do not seek treatment. The threshold is increasing in the waiting time since
Note that if the two groups have the same preferences and di¤er only in the distribution of health gain, all patients would have the same threshold at a given waiting time, irrespective of their group. Conversely, if they di¤er in the utility from treatment or non-treatment and have the same distributions, their thresholds will di¤er. For example if group A has more utility from treatment, then its threshold is lower: a member of group A would be more likely to seek treatment. However, the marginal individuals in both groups would have the same utility from treatment if their nontreatment utility is the same, irrespective of their treatment utility functions and their distribution functions.
Expected demand for treatment from individuals of type j is
where D j (w j ) is demand per person of type j. From (2) demand is decreasing in the waiting time
The empirical evidence shows that increases in waiting time reduce demand for health care (Gravelle, Smith and Xavier, 2003; Martin and Smith, 1999; Martin et al, 2007) .
Determination of waiting time
The supply of treatment allocated to group j is z j and total supply is z = P j z j : The waiting time w j (z j ) for group j is determined by
and is decreasing in supply
We assume P j j D j (0) > z. When there is no prioritisation patients in the two groups face the same waiting time w which is determined by P
where D j ( w) > 0. At w the di¤erent types have the same treatment threshold if and only if they have the same preferences. With a common waiting list and equal waiting times the amount of capacity allocated to type j is z j = j D j ( w). Note that although waiting time is the same, supply di¤ers in equilibrium for the di¤erent types.
Welfare
The planner knows the distribution functions but cannot prioritise individual patients on the basis of their health gain. Expected utility for potential patients of type j is
If one group's expected utility had a greater social value than the other it would be unsurprising that the groups would be o¤ered di¤erent waiting times. To focus on other factors determining their waiting times we assume that welfare is the sum of the expected utilities of the two types
Increasing w j reduces welfare from treatment:
where the term in the square brackets on the …rst line is zero because individuals make privately optimal decisions about demanding care and the welfare function respects these decisions. The marginal welfare cost of waiting per treated patient in group j is
3 Optimal third degree waiting time discrimination
The cost of treatment does not depend on the type of patient. Hence the problem of allocating a given amount of treatment requires that welfare S is maximised by choice of z j subject to P j z j z. Using the constraint to substitute z z A for z B , recalling (2), (4) and (6), the marginal welfare e¤ect of prioritising type A by increasing z A (and thereby reducing w A ) is
The signs of the …rst and second derivatives (see Appendix) of the welfare function with respect to z A depend on the speci…cs of the preferences and distributions of the two groups. But by inspecting (12) at z A = z A where w A = w B = w we see that Proposition 1 O¤ ering di¤ erent waiting times to groups waiting for a treatment (third degree waiting time discrimination) is always welfare increasing unless the groups have the same preferences and the same distribution of health gains from treatment.
Although the direction of prioritisation depends on the details of preferences and distributions of health gain we can provide an example where there is a de…nite conclusion. An alternative way to write (12) when the initial allocation has equal waiting times w A = w B = w is:
If both groups have the same preferences v T Aw (h;
Integrating by parts, we obtain
If the distribution of bene…t of group A strictly …rst order stochastically dominates that of group B, F A (h) < F B (h), h 2 (h min ; h max ), and if the marginal disutility of waiting is higher for patients with higher bene…t, v T wh < 0, then the …rst term is positive. If the demand of group B is more responsive than group A, i.e. D Bw > D Aw , then the second term is also positive, and prioritising group A is always welfare improving.
Proposition 2 If (a) the distribution of bene…t of group A strictly …rst order stochastically dominates that one of group B (F A (h) < F B (h); h 2 (h min ; h max )); (b) the marginal disutility of waiting is higher for patients with higher expected bene…t v T wh < 0 ; (c) demand of group B is more responsive than group A ( D Bw > D Aw ); then welfare is higher for some degree of prioritisation of group A (w A < w < w B ) than with no prioritisation (w A = w = w B ).
Using the de…nitions of the marginal welfare cost of waiting (11), we can write (12) in a more intuitively appealing form:
where " j = D jw w j =D j is the elasticity of demand by group j with respect to waiting time. Hence
Proposition 3 The optimal prioritisation scheme for patient groups A and B when both receive treatment at a positive waiting time, satis…es
Thus, if the marginal cost of waiting is identical across the two groups ( A = B ), the group with the less elastic demand will be prioritised by getting lower waiting times. If the elasticity of demand is identical across the two groups (" Aw = " Aw ), the group with the lower marginal cost of waiting will be prioritised by getting higher waiting times. Figure 1 provides an intuition for the welfare e¤ects of discrimination in a simple case where the two groups have the same size ( A = B = 1=2), and the same preferences. The utility of treated patients is v T j = h kw j . Thus the per patient marginal welfare cost of an increase in waiting time (32) is the same for both groups:
Total supply is the horizontal distance between the vertical axes. Supply to group A is measured rightwards from the left origin. All patients for whom h kw j demand treatment and the demand curve for group j is
The waiting time for each group is determined by the intersection of their demand curve and the vertical supply curve at z j .
The expected health gain from treatment for group j, net of waiting time costs, is j Rĥ j (h kw j )dF j which is the area below their demand curve and above the waiting time price line. Since waiting time costs are 8 deadweight losses, the allocation of the given total supply of treatment between the two groups should maximise their combined expected net health gain P j j Rĥ j (h kw j )dF j . Consider moving from an initial allocation z A = z A with equal waiting times ( w), to an allocation z o A < z A where group A has reduced supply and hence a higher waiting time than group B: w o A > w > w o B . The loss to group A which has the more elastic demand is a + b which is less than the gain to group B of d + e + f . Since total production cost is unchanged, welfare is increased by the discrimination in favour of group B which has less elastic demand at the initial no discrimination allocation.
The gross potential bene…t from treatment for the groups, before taking account of waiting time costs, is the area under their demand curves. Thus it is not necessarily welfare increasing to favour the group with higher potential bene…ts j R h min hdF j with a lower waiting time. Nor should priority necessarily be given to the group with greater bene…ts to treated patients j Rĥ j ( w) hdF j . Account must also be taken of how the two groups will respond to the changes in waiting times when prioritisation is introduced and capacity is shifted from one to the other.
Waiting time is a deadweight cost: it rations demand by imposing costs on users which are not o¤set by a gain to anyone else (Barzel, 1974) . Money prices also ration by imposing costs on users but these costs are o¤set by the revenue received by the producer. If the payments by patients have the same welfare weight as the resulting revenue and all patients have the same social weight, third degree price discrimination would be welfare reducing. The prices charged to the two groups should aim to maximise the sum of consumer surplus and producer pro…t. Given that the total supply is …xed this is equivalent to maximising willingness to pay or the sum of the areas under the demand curves in (money price, quantity) space. Thus, if we temporarily interpret w as a money price, so that Figure 1 plots demand curves for groups A and B in (money price, quantity) space, any move from the initial allocation z A with equal prices reduces the sum of the willingness to pay of the two groups. For example, the reallocation from z A to z o A gives a lower money price to group B and would reduce welfare by the area b + c. 3 Intuitively, with a …xed supply to allocate and with no distributional considerations, optimal allocation when there is rationing by money price maximises willingness to pay and when there is rationing by waiting time, it maximises consumer surplus. The di¤erence arises because waiting time imposes a deadweight loss. Figure 1 is also useful in illustrating the possibility of corner solutions and non-concavity of the welfare function even with plausible simple assumptions about preferences. A small shift from equal waiting times to higher waits for group A increases welfare. But this is only a local welfare improvement. Recall that the utility of treated patients are v T j = h kw j . Then, the marginal welfare e¤ect of increasing the allocation for group A is, using (6),
If the distributions have positive density over their supports then
so that there are local optima at both extreme prioritisation allocations where all the treatment is given to one group. There will also be an allocation where the …rst order condition is satis…ed but, if there is only one such allocation, it is a global minimum. In the example in Figure 1 welfare is maximised by giving all the supply to group B (setting them a wait of w B ) rather than giving it all to group A with a wait of w A . We can use (18) to state another set of assumptions about preferences which yields a de…nite conclusion about the direction of welfare increasing prioritisation. Distributions can be uniquely characterised by their hazard functions f j =(1 F j ). A distribution A is "strictly more favourable" than distribution B if Write (18) as
At w A = w B = w the term in the second line is zero and so (22) is positive if F A is more favourable than F B . Now evaluate (22) at w A < w < w B . The …rst term is positive. The second term is non-negative if the group B hazard rates is monotonically non-decreasing. Many common distributions such as the uniform, logistic, chi-squared, exponential and Laplace have non-decreasing hazard rates (La¤ont and Tirole, 1993, p.66 ).
This establishes
Proposition 4 (a) If both groups have the same separable preferences with linear waiting time costs: v T (h; w j ) = h kw j and group A has a more favourable distribution of bene…ts in the sense of (21), then some degree of prioritisation in favour of group A is welfare increasing compared with prioritisation. If (b) in addition, the hazard rates for group B is monotonically non-decreasing (d[f B =(1 F B )]=dh 0) then group A should be given complete priority ie it should get the entire supply of treatment.
Extension
We have so far made a number of simplifying assumptions: no e¤ect of treatment on other factors a¤ecting utility, zero charges for public sector care, and no alternative private sector supply of health care. We now show that relaxing these assumptions leaves the basic result about the welfare gain from third degree waiting time discrimination unchanged. Suppose that utility for a member of group j when treated in the public sector is v T j (y p; h; w j ) where y 2 [y min ; y max ] and p is the …xed user charge for public sector health care. There is a private sector where health care treatment with no wait is available at price m. Utility if treated in the private health care sector is v T j (y m; h; 0). We assume that m > p otherwise no patient ever demands care in the public sector. However we do not need to assume that p 0: individuals could be paid to consume public health care. Utility if not treated is v N T j (y). 4 All utility functions are concave in income and v T j is increasing in health gain and decreasing in the 4 The formulation allows for the possibility that receiving treatment can increase in-11 waiting time. We also assume that treatment increases the marginal utility of income v T jy (y; h; w) > v N T jy (y) and that marginal utility of income is not increased by a positive wait: v T jy (y; h; w) v T jy (y; h; 0). Patients choose public treatment to no treatment if v T j (y p; h; w j ) v N T j (y). The health gain threshold above which patients prefer public (government) treatment to no treatment isĥ GN j (y; p; w j ). The threshold is increasing in the waiting time and the user charge:
and decreasing in income:
Patients prefer public to private treatment if v T j (y p; b; w j ) v T j (y m; b; 0).ĥ GP j (y; p; m; w j ) is the threshold below which patients prefer public treatment to private treatment. It is decreasing in waiting time and in incomê
Patients prefer private treatment to no treatment if v T j (y m; h; 0) v N T j (y). The health gain threshold above which patients prefer private treatment to no treatment isĥ P N j (y; m). The threshold is decreasing in incomê
Patients with high bene…t and low income demand public treatment. Patients with high bene…t and high income demand private treatment. Patients with low bene…t demand no treatment.
come. Let y be income if treated, let income if not treated be y L(y), and denote utility if not treated asv N T (y L(y)). Then we can write v N T (y) =v N T (y L(y)). It also allows for a …xed user charge p for the treatment. Let utility if treated beṽ T (y p; h; wj) and write v T (y; h; wj) =ṽ T (y p; h; wj) without loss of generality since p does not vary across groups or with income or with waiting time.
The joint density and distribution functions over health gain and income for group j are f j (h; y) and F j (h; y). The expected demand for public treatment from group j is
. Increases in waiting time reduce demand for public treatment:
When waiting time increases some public sector patients decide not to be treated (…rst term) and some patients opt for the private sector (second term). Total welfare is the sum of the utility of public patients, private patients and patients with no treatment: S = S GT + S P T + S N T where
whereĥ P j (y; 
The …rst term is the e¤ect on public sector patients who decide not to be treated when the waiting time for the public sector increases. The second term is the e¤ect on public sector patients who decide to switch to the private sector. But since the welfare function respects the choices of patients both of these terms are zero. Thus the welfare e¤ect of an increase in waiting time is via its e¤ect on the utility of patients treated in the public sector.
Dividing (31) through by the number of treated patients ( j D j ) we can write the marginal social cost of an increase in waiting time for group j in the same way as (11) in Section 2.3:
The constraint on the welfare problem of allocating a …xed total supply of public sector care between the two groups is the same as in Section 3 and so Propositions 1 and 3 hold when there are user charges in the public sector, a private sector alternative, utility is not separable, and treatment a¤ects income.
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Conclusions
In many countries public sector health care treatments are rationed by waiting. We have investigated whether di¤erent groups of patients, de…ned by their preferences or distribution of bene…ts from treatment, waiting for the same treatment should be given di¤erent waiting times. We have shown that, even with a simple utilitarian social welfare function which respects individual choices and places the same weight on the utility of members of di¤erent groups of patients waiting for a treatment, it is in general welfare increasing to give di¤erent waiting times to the di¤erent groups of patients. The rationale is that rationing by waiting imposes deadweight losses: the cost of waiting imposed on patients is not o¤set by gains elsewhere. It is not necessarily the case that the groups with higher expected bene…t from the treatment should have shorter waits. Shorter waiting times should be offered to groups with higher marginal waiting time costs and with less elastic demand for the treatment.
